Meeting: 2017 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: 4014 Citation: J Clin Oncol 35, 2017 (suppl; abstr 4014) Authors: Yelena Yuriy Janjigian, Patrick Alexander Ott, Emiliano Calvo, et al. Background: In the phase 3 ONO-12 study, 3rd- or later-line nivolumab (N) monotherapy prolonged OS vs placebo in...
Pro zobrazení tohoto obsahu je třeba být přihlášen.